Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


MEHTA VIREN Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 4 MEHTA VIREN (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 66,468 options to buy @ $1.02, valued at $67.8k
08/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/27/2019 4 MEHTA VIREN (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Bought 250,000 shares @ $0.2, valued at $50k
Bought 250,000 options to buy @ $0.2, valued at $50k
07/29/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/30/2018 4 MEHTA VIREN (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 87,500 options to buy @ $0.46, valued at $40.3k
06/13/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/20/2016 4 MEHTA VIREN (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $0.52, valued at $5.2k
06/17/2015 4 MEHTA VIREN (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $2.69, valued at $26.9k
08/05/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
08/01/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
07/29/2013 4 MEHTA VIREN (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $15, valued at $150k
06/09/2010 4 MEHTA VIREN (Director) has filed a Form 4 on OSI PHARMACEUTICALS INC
Txns: Unknown transaction of 375 shares @ $57.5, valued at $21.6k
06/07/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
06/19/2009 4 MEHTA VIREN (Director) has filed a Form 4 on OSI PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy